About Cian Healthcare Limited
Data last updated: 25 June 2025
Cian Healthcare Limited is a public limited company based in Pune, Maharashtra, India. The company is currently undergoing Corporate Insolvency Resolution Process (CIRP) under the Insolvency and Bankruptcy Code, 2016. Management control has been transferred to an insolvency professional. It specialises in drug formulation and development, a part of the broader pharmaceuticals sector. Incorporated on 07 January 2003, the company has been in operation for over 23 years.
Registered with ROC Pune under CIN L24233PN2003PLC017563. Listed on BSE: 542678.
Capital: an authorised share capital of ₹25 Cr and a paid-up capital of ₹25 Cr. Formerly known as Cian Healthcare Private Limited. It is led by directors including Suraj Shriniwas Zanwar and Sunil Kumar.
Last AGM: 08 October 2024. Financial statements filed for year ended 31 March 2024. Office: 23A Harpale Park, Pune, Maharashtra.
As per BSE-filed consolidated financials for FY 2026, the company reported a revenue of ₹28.3 Cr, a decline of 8.12% compared to the previous year. Total assets are valued at ₹61.55 Cr (down 60.56% YoY).
The company has a workforce of approximately 140 employees as per the latest available data. Its group structure includes 1 subsidiary.
The company is associated with 3 brands - American Physician Institute, Cian Health Care, Mind Solutions. As per MCA filings, the company has open charges of ₹60.5 Cr and satisfied charges of ₹2.5 Lakh on record.
The company is undergoing Corporate Insolvency Resolution Process (CIRP) under the Insolvency and Bankruptcy Code, 2016. Management control has been transferred to an insolvency professional, and the company may not be able to independently enter into new commitments. The last known website on record is cian.co.
-
EmailLocked
-
TelephoneLocked
-
Website
-
Social Media
-
Registered AddressMilkat No.3339 Block No.1 From South Side C.S.No. 227/23A Harpale Park Opp.Berger Paint P, Hursungi, Pune, Maharashtra, India – 412308
-
IndustryPharma, Drug Formulation & Development
- Historical Financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Litigation, compliance and MCA filings
- PDF report delivered after checkout
CIN History of Cian Healthcare Limited
Cian Healthcare Limited has 2 previous CINs, indicating changes in the company's corporate structure or registration details. The current CIN is L24233PN2003PLC017563, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| L24233PN2003PLC017563 | Current |
| U24233PN2003PLC017563 | Previous |
| U24233PN2003PTC017563 | Previous |
Associated Brands with Cian Healthcare Limited
Cian Healthcare Limited operates multiple associated brands including American Physician Institute, Cian Health Care, and Mind Solutions. These brands represent Cian Healthcare Limited's diversified market presence and brand portfolio.
| Brand | Description | Website |
|---|---|---|
| Offers board review courses, CME programs, and career resources for physicians. | americanphysician.com | |
| Pharmaceuticals, OTCs, supplements, and veterinary products are manufactured. | cian.co | |
| Brain-computer interface systems for mind-machine interactions are developed. | mindsolutionscorp.com |
Competitors & Alternatives of Cian Healthcare Limited
Brands and companies operating in the same space as Cian Healthcare Limited include AMBOSS, Osmosis, MedBridge and 7 more.
| Competitor | Description | Location | Founded |
|---|---|---|---|
AMBOSS
|
Mobile and cloud-based resources for medical exams are delivered. | Berlin, Germany, Germany | 2012 |
Osmosis
|
Educational resources platform for medical students and professionals | Charlottesville, United States, United States | 2012 |
MedBridge
|
Healthcare education and patient care software solutions are provided. | Bellevue, United States, United States | 2010 |
Lecturio
|
Online medical education platform for professionals and students is operated. | Leipzig, Germany, Germany | 2008 |
HealthStream
|
Cloud-based learning management solutions are offered for healthcare organizations. | Nashville, United States, United States | 1990 |
Picmonic
|
Visual learning platform is provided for medical students' exam preparation. | Tucson, United States, United States | 2011 |
Orbis Education
|
Healthcare training and workforce placement platform is provided. | Indianapolis, United States, United States | 2003 |
Relias
|
A learning management platform for healthcare is provided. | Morrisville, United States, United States | 2012 |
South China Brain Control Intelligent Technology
|
AI-based brain-computer interfaces are provided for device interactions. | Guangzhou, China, China | 2019 |
Thought-Wired
|
Brain-computer interfaces are developed for thought-based communication and applications. | Auckland, New Zealand, New Zealand | 2010 |
Business Activity of Cian Healthcare Limited
Cian Healthcare Limited is engaged in the principal business activity of manufacturing, with detailed activities including chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products | Locked |
Business activity turnover details for Cian Healthcare Limited
Turnover contribution percentages and historical activity changes require an active report plan.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Auditor Details of Cian Healthcare Limited
Cian Healthcare Limited is audited by M/s SSRCA & Co (ICAI peer reviewed, certificate valid till 2027-07-31) for the financial year 2026, as reported in its BSE exchange filings. The statutory auditor is responsible for expressing an independent opinion on whether the financial statements present a true and fair view in accordance with applicable accounting standards.
| Name | Financial year | Audit opinion |
|---|---|---|
| M/s SSRCA & Co (ICAI peer reviewed, certificate valid till 2027-07-31) | FY 2026 | Statement on impact of audit qualification |
Board of Directors of Cian Healthcare Limited
Cian Healthcare Limited is currently managed by 3 directors, with 21 former directors having served the organization. The current Directors play a crucial role in shaping the company's strategic direction and governance.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Suraj Shriniwas Zanwar | Managing Director | 07 Jan 2003 | 23 Years 6 Months | As last reported |
| Sunil Kumar | Director | 03 Sep 2022 | 3 Years 10 Months | As last reported |
| Santosh Shivaji Pimparkar | Director | 11 Oct 2023 | 2 Years 9 Months | As last reported |
Financials of Cian Healthcare Limited FY 2026 filings available
Cian Healthcare Limited reported revenue of ₹28.3 Cr (down 8.12% YoY) for FY 2026.
| Metrics | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|---|
| Revenue from Operations | ₹28.3 Cr | ₹30.8 Cr | ₹61.7 Cr | ₹68.59 Cr | ₹77.87 Cr | ₹73.73 Cr | ₹57.09 Cr |
| Other Income | ₹1.17 Cr | ₹26.82 Lakh | ₹44.07 Lakh | ₹61.8 Lakh | ₹53.62 Lakh | ₹28.04 Lakh | ₹86.27 Lakh |
| Total Income | ₹29.47 Cr | ₹31.07 Cr | - | - | - | - | ₹57.95 Cr |
| Cost of Materials Consumed | ₹16.66 Cr | ₹9.23 Cr | ₹37.14 Cr | ₹26.37 Cr | ₹49.66 Cr | ₹34.37 Cr | ₹33.59 Cr |
| Purchases of Stock-in-Trade | ₹22.97 Lakh | ₹4.08 Cr | ₹3.98 Cr | ₹10.12 Cr | ₹5.12 Cr | ₹9.65 Cr | ₹0 |
| Changes in Inventories | ₹5.64 Cr | ₹9.38 Cr | -₹10.38 Cr | -₹3.05 Cr | -₹6.88 Cr | -₹3.55 Cr | ₹0 |
| Employee Benefit Expense | ₹5.88 Cr | ₹7.01 Cr | ₹8.57 Cr | ₹9.41 Cr | ₹9.86 Cr | ₹7.16 Cr | ₹4.68 Cr |
| Finance Costs | ₹21.44 Lakh | ₹2.92 Cr | ₹5.79 Cr | ₹5.69 Cr | ₹6.44 Cr | ₹7.72 Cr | ₹7.12 Cr |
| Depreciation & Amortisation | - | - | - | - | - | - | ₹4.45 Cr |
| Other Expenses | ₹6.81 Cr | ₹7.81 Cr | ₹11.52 Cr | ₹13.36 Cr | ₹15.86 Cr | ₹14.31 Cr | ₹11.63 Cr |
| Total Expenses | ₹39.35 Cr | ₹44.81 Cr | ₹62.09 Cr | ₹67.33 Cr | ₹84.34 Cr | ₹73.11 Cr | ₹61.48 Cr |
| Profit Before Exceptional Items & Tax | - | - | - | - | - | - | -₹3.52 Cr |
| Exceptional Items | - | - | - | - | - | - | ₹0 |
| Profit Before Tax | -₹23.18 Cr | -₹26 Cr | ₹5.22 Lakh | ₹1.99 Cr | -₹6 Cr | ₹68.7 Lakh | -₹3.52 Cr |
| Total Tax Expense | ₹11.21 Lakh | -₹1.78 Lakh | -₹20.21 Lakh | -₹3.87 Lakh | -₹46.96 Lakh | ₹63.4 Lakh | ₹26.32 Lakh |
| Net Profit | -₹23.29 Cr | -₹25.98 Cr | ₹25.43 Lakh | ₹2.03 Cr | -₹5.53 Cr | ₹5.31 Lakh | -₹3.79 Cr |
| Other Comprehensive Income | - | - | - | - | - | - | ₹0 |
| Total Comprehensive Income | - | - | - | - | - | - | -₹3.79 Cr |
| EBITDA (computed) | - | - | - | - | - | - | ₹8.04 Cr |
| Basic EPS | - | - | - | - | - | - | ₹-1.62 |
| Diluted EPS | - | - | - | - | - | - | ₹-1.62 |
| Metrics | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|---|
| Total Assets | ₹61.55 Cr | ₹156.06 Cr | ₹161.18 Cr | ₹160.48 Cr | ₹165.94 Cr | ₹157.25 Cr | ₹156.43 Cr |
| Non-current Assets | ₹38.67 Cr | ₹85.22 Cr | ₹89.43 Cr | ₹86.24 Cr | ₹86.98 Cr | ₹93.89 Cr | ₹79.55 Cr |
| Current Assets | ₹22.88 Cr | ₹70.84 Cr | ₹71.74 Cr | ₹74.24 Cr | ₹78.96 Cr | ₹63.37 Cr | ₹76.88 Cr |
| Property, Plant & Equipment | ₹31.84 Cr | ₹34.93 Cr | - | - | - | - | ₹39.43 Cr |
| Inventories | ₹5.05 Cr | ₹26.08 Cr | ₹40.93 Cr | ₹36.64 Cr | ₹39.37 Cr | ₹30.73 Cr | ₹19.72 Cr |
| Trade Receivables | - | - | - | - | - | - | ₹19.99 Cr |
| Cash & Equivalents | ₹1.2 Cr | ₹17.77 Cr | ₹1.19 Cr | ₹1.33 Cr | ₹1.34 Cr | ₹2.32 Cr | ₹4.45 Cr |
| Equity (Net Worth) | - | - | - | - | - | - | ₹58.19 Cr |
| Equity Share Capital | - | - | - | - | - | - | ₹23.36 Cr |
| Borrowings (Non-current) | - | - | - | - | - | - | ₹45.84 Cr |
| Borrowings (Current) | - | - | - | - | - | - | ₹27.32 Cr |
| Total Debt (computed) | - | - | - | - | - | - | ₹73.16 Cr |
| Current Liabilities | ₹29.15 Cr | ₹114.49 Cr | ₹66.11 Cr | ₹65.27 Cr | ₹69.45 Cr | ₹57.79 Cr | ₹50.03 Cr |
| Total Liabilities | - | - | - | - | - | - | ₹98.24 Cr |
| Metrics | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
| Operating Cash Flow | ₹20.51 Cr | ₹20.71 Cr | ₹11.76 Cr | ₹4.84 Cr | ₹8.58 Cr |
| Investing Cash Flow | ₹13.27 Cr | -₹25.56 Lakh | -₹1.46 Cr | ₹2.55 Cr | ₹1.4 Cr |
| Financing Cash Flow | -₹50.35 Cr | -₹3.92 Cr | -₹10.44 Cr | -₹7.41 Cr | -₹10.96 Cr |
| Capital Expenditure | -₹8.09 Cr | ₹40.56 Lakh | - | - | - |
| Free Cash Flow (computed) | ₹12.42 Cr | ₹20.31 Cr | - | - | - |
| Dividends Paid | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 |
| Net Change in Cash | -₹16.57 Cr | ₹16.54 Cr | -₹13.55 Lakh | -₹1.19 Lakh | -₹98.32 Lakh |
| Metrics | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|---|---|---|
| Revenue from Operations | ₹28.3 Cr | ₹30.88 Cr | ₹58.75 Cr | ₹67.56 Cr | ₹64.1 Cr | ₹72.38 Cr | ₹57.05 Cr | ₹62.44 Cr |
| Other Income | ₹1.16 Cr | ₹25.27 Lakh | ₹1.06 Cr | ₹53.81 Lakh | ₹47.06 Lakh | ₹20.3 Lakh | ₹78.9 Lakh | ₹95.43 Lakh |
| Total Income | ₹29.46 Cr | ₹31.14 Cr | - | - | - | - | ₹57.83 Cr | - |
| Cost of Materials Consumed | ₹16.66 Cr | ₹18.58 Cr | ₹41.48 Cr | ₹35.69 Cr | ₹40.19 Cr | ₹35.03 Cr | ₹33.6 Cr | ₹0 |
| Purchases of Stock-in-Trade | ₹22.97 Lakh | ₹1.48 Cr | ₹3.2 Cr | ₹10.11 Cr | ₹5.01 Cr | ₹9.16 Cr | ₹0 | ₹45.3 Cr |
| Changes in Inventories | ₹5.64 Cr | ₹23.21 Lakh | -₹10.65 Cr | -₹4.85 Cr | -₹6.96 Cr | -₹1.28 Cr | ₹0 | -₹11.67 Lakh |
| Employee Benefit Expense | ₹5.88 Cr | ₹6.65 Cr | ₹7.6 Cr | ₹8.06 Cr | ₹8.2 Cr | ₹6.93 Cr | ₹4.6 Cr | ₹5.63 Cr |
| Finance Costs | ₹20.97 Lakh | ₹2.04 Cr | ₹4.73 Cr | ₹4.18 Cr | ₹5.14 Cr | ₹6.21 Cr | ₹5.81 Cr | ₹5.1 Cr |
| Depreciation & Amortisation | - | - | - | - | - | - | ₹2.45 Cr | - |
| Other Expenses | ₹6.32 Cr | ₹6.97 Cr | ₹9.77 Cr | ₹10.09 Cr | ₹12.73 Cr | ₹13.22 Cr | ₹11.3 Cr | ₹3.49 Cr |
| Total Expenses | ₹37.07 Cr | ₹38.56 Cr | ₹59.8 Cr | ₹66.93 Cr | ₹66.88 Cr | ₹71.72 Cr | ₹57.76 Cr | ₹62.32 Cr |
| Profit Before Exceptional Items & Tax | - | - | - | - | - | - | ₹7.46 Lakh | - |
| Exceptional Items | - | - | - | - | - | - | ₹0 | - |
| Profit Before Tax | -₹20.91 Cr | -₹19.67 Cr | ₹1.26 Lakh | ₹1.2 Cr | -₹2.38 Cr | ₹66.5 Lakh | ₹7.46 Lakh | ₹94.07 Lakh |
| Total Tax Expense | ₹11.21 Lakh | -₹1.77 Lakh | -₹37.7 Lakh | ₹12.36 Lakh | -₹9.94 Lakh | ₹33.83 Lakh | ₹14.7 Lakh | ₹28.55 Lakh |
| Net Profit | -₹21.02 Cr | -₹19.66 Cr | ₹38.96 Lakh | ₹1.08 Cr | -₹2.28 Cr | ₹32.67 Lakh | -₹7.24 Lakh | ₹65.52 Lakh |
| Other Comprehensive Income | - | - | - | - | - | - | ₹0 | - |
| Total Comprehensive Income | - | - | - | - | - | - | -₹7.24 Lakh | - |
| EBITDA (computed) | - | - | - | - | - | - | ₹8.34 Cr | - |
| Basic EPS | - | - | - | - | - | - | ₹-0.03 | - |
| Diluted EPS | - | - | - | - | - | - | ₹-0.03 | - |
| Metrics | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|---|---|---|
| Total Assets | ₹48.22 Cr | ₹142.68 Cr | ₹142.89 Cr | ₹140.63 Cr | ₹139.78 Cr | ₹134.63 Cr | ₹134.58 Cr | ₹79.88 Cr |
| Non-current Assets | ₹30.83 Cr | ₹75.7 Cr | ₹78.13 Cr | ₹72.39 Cr | ₹70.99 Cr | ₹76.96 Cr | ₹61.39 Cr | ₹38.95 Cr |
| Current Assets | ₹17.39 Cr | ₹66.97 Cr | ₹64.76 Cr | ₹68.24 Cr | ₹68.79 Cr | ₹57.67 Cr | ₹73.19 Cr | ₹40.92 Cr |
| Property, Plant & Equipment | ₹22.01 Cr | ₹23.32 Cr | - | - | - | - | ₹20.78 Cr | - |
| Inventories | ₹4.59 Cr | ₹25.62 Cr | ₹37.68 Cr | ₹34.81 Cr | ₹34.02 Cr | ₹25.71 Cr | ₹19.72 Cr | ₹15.95 Cr |
| Trade Receivables | - | - | - | - | - | - | ₹19.95 Cr | - |
| Cash & Equivalents | ₹1.13 Cr | ₹17.66 Cr | ₹72.74 Lakh | ₹1.13 Cr | ₹1.22 Cr | ₹2.21 Cr | ₹3.02 Cr | ₹2.33 Cr |
| Equity (Net Worth) | - | - | - | - | - | - | ₹59.55 Cr | - |
| Equity Share Capital | - | - | - | - | - | - | ₹23.36 Cr | - |
| Borrowings (Non-current) | - | - | - | - | - | - | ₹24.49 Cr | - |
| Borrowings (Current) | - | - | - | - | - | - | ₹26.94 Cr | - |
| Total Debt (computed) | - | - | - | - | - | - | ₹51.43 Cr | - |
| Current Liabilities | ₹10.04 Cr | ₹97.59 Cr | ₹56.16 Cr | ₹57.99 Cr | ₹56.87 Cr | ₹53.05 Cr | ₹48.57 Cr | ₹33.44 Cr |
| Total Liabilities | - | - | - | - | - | - | ₹75.03 Cr | - |
| Metrics | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
| Operating Cash Flow | ₹20.45 Cr | ₹20.66 Cr | ₹6.94 Cr | ₹2.15 Cr | ₹5.51 Cr |
| Investing Cash Flow | ₹13.36 Cr | -₹26.75 Lakh | -₹92.62 Lakh | -₹1.08 Cr | -₹3.85 Cr |
| Financing Cash Flow | -₹50.34 Cr | -₹3.46 Cr | -₹6.41 Cr | -₹1.17 Cr | -₹2.65 Cr |
| Capital Expenditure | ₹0 | ₹3.88 Lakh | - | - | - |
| Free Cash Flow (computed) | ₹20.45 Cr | ₹20.62 Cr | - | - | - |
| Dividends Paid | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 |
| Net Change in Cash | -₹16.53 Cr | ₹16.93 Cr | -₹39.82 Lakh | -₹9.7 Lakh | -₹98.68 Lakh |
Shareholding Pattern of Cian Healthcare Limited
As per the shareholding pattern filed with BSE for the quarter ended Mar 2026, promoters hold 95.00%, retail and other public shareholders hold 5.00% of Cian Healthcare Limited. The company had 1,683 shareholders on record.
| Mar 2026 | Sep 2025 | Mar 2025 | Sep 2024 | Jun 2024 | Mar 2024 | |
|---|---|---|---|---|---|---|
| Promoters | 95.00% | 27.10% | 27.10% | 27.10% | 27.10% | 27.10% |
| Public | 5.00% | 72.90% | 72.90% | 72.90% | 72.90% | 72.90% |
| Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | |
|---|---|---|---|---|---|
| Promoters | 95.00% | 27.10% | 27.10% | 51.85% | 66.26% |
| Public | 5.00% | 72.90% | 72.90% | 48.15% | 33.74% |
| Promoter change (YoY, %pts) | +67.90 | +0.00 | -24.75 | -14.41 | - |
Group Structure of Cian Healthcare Limited
Cian Healthcare Limited has 1 subsidiary company. This group structure data is as of FY 2024. The corporate group structure reflects Cian Healthcare Limited's business expansion strategy and organizational complexity.
| Company Name | CIN | Shares Held |
|---|---|---|
| Dr. Smiths Biotech Private Limited | U24246PN2015PTC154818 | - |
Showing major subsidiaries. Total: 1.
Charges & Borrowings of Cian Healthcare Limited
| Date | Lender | Amount | Status |
|---|---|---|---|
| 16 Sep 2009 | Idbi Bank Limited | ₹60.5 Cr | Open |
| 24 Jun 2011 | Cholamandalam Investment and Finance Company Limited | ₹2.5 Lakh | Satisfied |
Total charge records: 2 View all charges
Employees and EPFO Compliance at Cian Healthcare Limited
Cian Healthcare Limited has a workforce of 140 employees as of Mar 29, 2025.
Employee and EPFO history for Cian Healthcare Limited
Monthly headcount, contribution history, establishment records, and filing compliance require an active report plan.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
GST Compliance of Cian Healthcare Limited
GST registrations and filing compliance for Cian Healthcare Limited
State-wise registrations, return filing status, HSN and SAC details, and jurisdiction records require an active report plan.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
Credit Ratings, Litigation & Regulatory Alerts for Cian Healthcare Limited
Credit ratings, litigation, and regulatory alerts for Cian Healthcare Limited
Agency ratings, court records, regulatory events, and entity-specific compliance alerts require an active report plan.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Cian Healthcare Limited
MSME payment history for Cian Healthcare Limited
Amounts outstanding to micro and small suppliers, delay reasons, and MSME-1 filing history require an active report plan.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Cian Healthcare Limited
Corporate group structure for Cian Healthcare Limited
Parent, subsidiary, associate, joint venture, and ownership records require an active report plan.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Cian Healthcare Limited
MCA filings and documents for Cian Healthcare Limited
Official forms, annual returns, financial statements, charge filings, and document dates require an active report plan.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Recent Activity on Cian Healthcare Limited
Frequently Asked Questions about Cian Healthcare Limited
Cian Healthcare Limited is undergoing "Corporate Insolvency Resolution Process" (CIRP) under the Insolvency and Bankruptcy Code, 2016. Management control has been transferred to an insolvency resolution professional. The company may not be able to independently enter into new commitments during this period. This is a high-risk status - verify the resolution status before any engagement.
Cian Healthcare Limited is a company under insolvency, formerly operating as a public limited company in the pharma sector based in Pune, Maharashtra, India. It was incorporated on 07 January 2003 and is registered under CIN L24233PN2003PLC017563. Listed on BSE: 542678. Caution is advised - the company may not have the legal capacity to fulfil new agreements.
Cian Healthcare Limited reported revenue of ₹28.3 Cr for FY 2026 (down 8.12% YoY) based on consolidated BSE filings.
The current directors of Cian Healthcare Limited are:
- Suraj Shriniwas Zanwar - Managing Director
- Sunil Kumar - Director
- Santosh Shivaji Pimparkar - Director
The CIN (Corporate Identification Number) of Cian Healthcare Limited is L24233PN2003PLC017563. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Yes. Cian Healthcare Limited is listed on BSE with code 542678.